K.N. Biosciences (India) Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 13-12-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.48 Cr
as on 13-12-2024
- Satisfied Charges ₹ 2.80 Cr
as on 13-12-2024
- Revenue 10.25%
(FY 2022)
- Profit 29.81%
(FY 2022)
- Ebitda 17.53%
(FY 2022)
- Net Worth 7.84%
(FY 2022)
- Total Assets 12.70%
(FY 2022)
About K.N. Biosciences (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹12.48 Cr. The company has closed loans amounting to ₹2.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Usha Muthyala and Sudha Punuru serve as directors at the Company.
- CIN/LLPIN
U24299TG2003PTC041943
- Company No.
041943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationNa, Telangana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does K.N. Biosciences (India) Private Limited offer?
K.N. Biosciences (India) Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Bio Insecticides, Nitrogen Fertilizers, NPK Fertilizer, Gud Jaggery, Organic Jaggery Powder, Biofungicides, Pseudomonas Fluorescens, Fertilizers and Soil Additives, Fertilizer.
Who are the key members and board of directors at K.N. Biosciences (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Punuru  | Managing Director | 23-Oct-2003 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Usha Muthyala | Director | 23-Oct-2003 | Current |
Financial Performance and Corporate Structure Insights of K.N. Biosciences (India).
K.N. Biosciences (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.25% increase. The company also saw a substantial improvement in profitability, with a 29.81% increase in profit. The company's net worth moved up by a moderate rise of 7.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K.N. Biosciences (India)?
In 2022, K.N. Biosciences (India) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jun 2023 | ₹4.50 Cr | Open |
Others Creation Date: 22 Jun 2023 | ₹1.77 M | Open |
Others Creation Date: 22 Jun 2023 | ₹1.61 M | Open |
How Many Employees Work at K.N. Biosciences (India)?
K.N. Biosciences (India) has a workforce of 43 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K.N. Biosciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K.N. Biosciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
